TMDI - Titan Medical Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
17.58M
Enterprise Value 3
6.19M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-0.10

Trading Information

Stock Price History

Beta (3Y Monthly) 6.15
52-Week Change 3-73.68%
S&P500 52-Week Change 313.33%
52 Week High 34.6500
52 Week Low 30.3800
50-Day Moving Average 30.7283
200-Day Moving Average 31.9006

Share Statistics

Avg Vol (3 month) 3567.04k
Avg Vol (10 day) 31.36M
Shares Outstanding 533.57M
Float 30.91M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct 31, 2019) 41.14M
Short Ratio (Oct 31, 2019) 41.19
Short % of Float (Oct 31, 2019) 4N/A
Short % of Shares Outstanding (Oct 31, 2019) 42.23%
Shares Short (prior month Sep 30, 2019) 41.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 230/1
Last Split Date 3Jun 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-162.55%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -63.73M
Net Income Avi to Common (ttm)-58.7M
Diluted EPS (ttm)-2.4870
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.32M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.50
Book Value Per Share (mrq)-0.59

Cash Flow Statement

Operating Cash Flow (ttm)-61.22M
Levered Free Cash Flow (ttm)-24.41M